Study of semaglutide effects on glycemic control and body weight in diverse T2D populations confirms consistent efficacy across different patient demographics.
Key findingStudy of semaglutide effects on glycemic control and body weight in diverse T2D populations confirms
What the researchers found
Study of semaglutide effects on glycemic control and body weight in diverse T2D populations confirms consistent efficacy across different patient demographics.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
238 patients studied. Electronic health record data from a primary care clinic in Jeddah, Saudi Arabia.
How the study worked
In publication.
Who was studied
238 adults with type 2 diabetes in primary care in Jeddah, Saudi Arabia
What this study cannot tell us
In publication.
How to read the evidence
Based on study design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide therapeutic knowledge.
Questions still open
- Long-term implications?
- Comparison to evidence?
- Next research?
Common questions
What does this mean?
How reliable?
Read the original research
Effects of Semaglutide on Glycemic Control and Body Weight in Patients With Type 2 Diabetes: A Retrospective Cohort Study in a Primary Care Setting.
Cureus, 17(4), e82123
Citation
Alzahrani, Mahmoud; Rammal, Lama; Felemban, Razaz; Khan, Muhammed; Saad, Hamza; Alrezqi, Muhammed; Alsulami, Nabil; Alabdullatif, Abdulelah; Alawashiz, Zyad. (2025). Effects of Semaglutide on Glycemic Control and Body Weight in Patients With Type 2 Diabetes: A Retrospective Cohort Study in a Primary Care Setting.. Cureus, 17(4), e82123. https://doi.org/10.7759/cureus.82123